These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 11288955)
1. Circulating angiogenesis regulators in cancer patients. Kuroi K; Toi M Int J Biol Markers; 2001; 16(1):5-26. PubMed ID: 11288955 [TBL] [Abstract][Full Text] [Related]
2. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus. Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T Lupus; 2002; 11(6):348-55. PubMed ID: 12139372 [TBL] [Abstract][Full Text] [Related]
3. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma. Dhar DK; Ono T; Yamanoi A; Soda Y; Yamaguchi E; Rahman MA; Kohno H; Nagasue N Cancer; 2002 Nov; 95(10):2188-95. PubMed ID: 12412173 [TBL] [Abstract][Full Text] [Related]
5. Serum endostatin levels are elevated in patients with soft tissue sarcoma. Feldman AL; Pak H; Yang JC; Alexander HR; Libutti SK Cancer; 2001 Apr; 91(8):1525-9. PubMed ID: 11301401 [TBL] [Abstract][Full Text] [Related]
6. Elevated levels of angiogenic cytokines in the plasma of cancer patients. Fuhrmann-Benzakein E; Ma MN; Rubbia-Brandt L; Mentha G; Ruefenacht D; Sappino AP; Pepper MS Int J Cancer; 2000 Jan; 85(1):40-5. PubMed ID: 10585580 [TBL] [Abstract][Full Text] [Related]
7. Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma. Sezer O; Jakob C; Eucker J; Niemöller K; Gatz F; Wernecke K; Possinger K Eur J Haematol; 2001 Feb; 66(2):83-8. PubMed ID: 11168514 [TBL] [Abstract][Full Text] [Related]
8. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma? Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646 [TBL] [Abstract][Full Text] [Related]
10. Biomarkers of intrinsic angiogenic and anti-angiogenic activity in patients with endometrial hyperplasia and endometrial cancer. Shaarawy M; El-Sharkawy SA Acta Oncol; 2001; 40(4):513-8. PubMed ID: 11504312 [TBL] [Abstract][Full Text] [Related]
11. Angiogenic factors as tumor markers. Nguyen M Invest New Drugs; 1997; 15(1):29-37. PubMed ID: 9195287 [TBL] [Abstract][Full Text] [Related]
12. Serum levels of vascular endothelial growth factor, basic fibroblast growth factor and endostatin in human metastatic liver tumors. Miyashita M; Tajiri T; Yanagi K; Shimizu T; Futami R; Sasajima K; Tokunaga A Hepatogastroenterology; 2003; 50(50):308-9. PubMed ID: 12749209 [TBL] [Abstract][Full Text] [Related]
13. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. Ugurel S; Rappl G; Tilgen W; Reinhold U J Clin Oncol; 2001 Jan; 19(2):577-83. PubMed ID: 11208853 [TBL] [Abstract][Full Text] [Related]
14. Circulating angiogenic cytokines as tumour markers and prognostic factors in head and neck squamous cell carcinoma. Homer JJ; Greenman J; Stafford ND Clin Otolaryngol Allied Sci; 2002 Feb; 27(1):32-7. PubMed ID: 11903369 [TBL] [Abstract][Full Text] [Related]
15. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Dirix LY; Vermeulen PB; Pawinski A; Prové A; Benoy I; De Pooter C; Martin M; Van Oosterom AT Br J Cancer; 1997; 76(2):238-43. PubMed ID: 9231925 [TBL] [Abstract][Full Text] [Related]
16. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314 [TBL] [Abstract][Full Text] [Related]
17. Plasma VEGF concentration can predict the tumor angiogenic capacity in non-small cell lung cancer. Tamura M; Ohta Y; Kajita T; Kimura K; Go T; Oda M; Nakamura H; Watanabe G Oncol Rep; 2001; 8(5):1097-102. PubMed ID: 11496323 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery. Chao Y; Li CP; Chau GY; Chen CP; King KL; Lui WY; Yen SH; Chang FY; Chan WK; Lee SD Ann Surg Oncol; 2003 May; 10(4):355-62. PubMed ID: 12734082 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor and basic fibroblast growth factor in patients with squamous cell oesophageal cancer. Wallner G; Ciechański A; Dabrowski A; Kozłowski M; Roliński J; Laudański J; Cwik G Folia Histochem Cytobiol; 2001; 39 Suppl 2():122-3. PubMed ID: 11820569 [TBL] [Abstract][Full Text] [Related]
20. Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma. Akbulut H; Altuntas F; Akbulut KG; Ozturk G; Cindoruk M; Unal E; Icli F Cytokine; 2002 Nov; 20(4):184-90. PubMed ID: 12543084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]